BETA: Please send your feedback!
Jeil Pharmaceutical
271980-KR:KRX
Pharmaceuticals: Major
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- 5
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
About
Pharmaceuticals: Major
Founded 2017
Jeil Pharmaceutical Co., Ltd. engages in developing pharmaceuticals. It provides drugs for Antibiotic, Oncology, Cardiovascular, Gatrointestinal, Neuropsychiatry, Urology, Endocrinology, Respiratory, Antiviral, Musculoskeletal and other divisions. The company was founded on June 1, 2017 and is headquartered in Seoul, South Korea.
website
Headquarters
Executives
Name | Title | Gender |
Mindful Investing Summary
Jeil Pharmaceutical - Competitors and Related Companies
How Jeil Pharmaceutical stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
Jeil Pharmaceutical
271980-KR:KRX
Pharmaceuticals: Major
—
SMALL cap
(—)
—
since start of 2021
—
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
- —
-
Carbon Footprint
-
Pollution Prevention
-
Water Conservation
-
Data & Privacy Protection
-
Consumer Health, Wellness & Safety
-
Employee Ownership, Satisfaction, Benefits & Pay
-
Workplace Health and Safety
-
Integrity of Corporate Governance
-
Ethical Practices
-
Usage of Conflict Materials
-
Forced Labor
-
Diversity of Corporate Leadership
Loading…